When used in combination with e23AON, 30–70 mg/kg/day dantrolene modestly increased e23-skipped mRNA, dystrophin protein expression, and rescue of pathophysiology after 6 months of chronic dosing in the mdx DMD mouse model. Here, DMD is linked to Duchenne muscular dystrophy.